DE69333497D1 - Antikrebs-therapeutische zusammensetzungen die molke-proteinkonzentrat enthalten - Google Patents

Antikrebs-therapeutische zusammensetzungen die molke-proteinkonzentrat enthalten

Info

Publication number
DE69333497D1
DE69333497D1 DE69333497T DE69333497T DE69333497D1 DE 69333497 D1 DE69333497 D1 DE 69333497D1 DE 69333497 T DE69333497 T DE 69333497T DE 69333497 T DE69333497 T DE 69333497T DE 69333497 D1 DE69333497 D1 DE 69333497D1
Authority
DE
Germany
Prior art keywords
whey protein
protein concentrate
compositions containing
therapeutic compositions
cancer therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69333497T
Other languages
English (en)
Other versions
DE69333497T2 (de
Inventor
Phil Gold
Gustavo Bounous
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
2458781 CANADA INC., VAUDREUIL, QUEBEC, CA
Original Assignee
Immunotec Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunotec Research Corp filed Critical Immunotec Research Corp
Publication of DE69333497D1 publication Critical patent/DE69333497D1/de
Application granted granted Critical
Publication of DE69333497T2 publication Critical patent/DE69333497T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Steroid Compounds (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE1993633497 1992-08-13 1993-08-05 Antikrebs-therapeutische zusammensetzungen die molke-proteinkonzentrat enthalten Expired - Lifetime DE69333497T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92934792A 1992-08-13 1992-08-13
US929347 1992-08-13
PCT/CA1993/000309 WO1994004168A1 (en) 1992-08-13 1993-08-05 Anti-cancer therapeutic compositions containing whey protein concentrate

Publications (2)

Publication Number Publication Date
DE69333497D1 true DE69333497D1 (de) 2004-06-03
DE69333497T2 DE69333497T2 (de) 2005-01-13

Family

ID=25457715

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1993633497 Expired - Lifetime DE69333497T2 (de) 1992-08-13 1993-08-05 Antikrebs-therapeutische zusammensetzungen die molke-proteinkonzentrat enthalten

Country Status (15)

Country Link
EP (1) EP0655925B1 (de)
JP (2) JP4115515B2 (de)
KR (1) KR100297610B1 (de)
CN (1) CN1088095A (de)
AT (1) ATE265217T1 (de)
AU (1) AU687356B2 (de)
CA (1) CA2142277C (de)
CZ (1) CZ295849B6 (de)
DE (1) DE69333497T2 (de)
IL (1) IL106576A (de)
MX (1) MX9304925A (de)
NZ (1) NZ254704A (de)
TW (1) TW380051B (de)
WO (1) WO1994004168A1 (de)
ZA (1) ZA935918B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
TWI438675B (zh) 2010-04-30 2014-05-21 Ibm 提供情境感知援助說明之方法、裝置及電腦程式產品
CN102232556A (zh) * 2010-04-30 2011-11-09 李德远 一种抗偏二甲肼的食品添加剂
BR112014013565A2 (pt) * 2011-12-07 2019-09-24 Arla Foods Amba variante da opn para uso no tratamento ou prevenção de câncer envolvendo pelo menos um tumor canceroso, método de tratamento ou prevenção do câncer, composição farmacêutica e suplemento nutricional
DE102014001037A1 (de) * 2014-01-25 2015-07-30 Gea Tds Gmbh Verfahren und Vorrichtung zur Reduzierung des Wachstums thermophiler Keime in Magermilch
CN104146269B (zh) * 2014-07-28 2015-08-19 苏喜生 一种用于抗偏二甲肼的应激食品添加剂及其制备方法
CN105831769A (zh) * 2015-02-04 2016-08-10 张亚武 一种细胞内/细胞间对癌症抑制之食物
WO2018057514A1 (en) 2016-09-23 2018-03-29 Immunotec Inc. Compositions for restoring gene expression in neuropsychiatric or neurodegenerative disorders
CA2970699A1 (en) 2017-06-14 2018-12-14 Elizabeth E. Ignowski Compositions for increasing resilience to traumatic brain injury
WO2019027974A1 (en) 2017-07-31 2019-02-07 Immunotec Inc. COMPOSITIONS AND METHODS FOR TREATING AUTISM SPECTRUM DISORDER

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3628010A1 (de) * 1986-08-19 1988-02-25 Astra Chem Gmbh Arzneimittel fuer die verwendung bei der behandlung von hypertonie
DE3870247D1 (de) * 1988-12-21 1992-05-21 Siemens Ag Schienenfahrzeug.
CA1338682C (en) * 1988-12-23 1996-10-29 Gustavo Bounous Biologically active undenatured whey protein concentrate as food supplement
JPH03216156A (ja) * 1990-01-22 1991-09-24 Gustavo Bounous 生物学的に活性なホエータンパク質組成物、その製法および組成物の使用法

Also Published As

Publication number Publication date
JP4115515B2 (ja) 2008-07-09
NZ254704A (en) 1997-08-22
IL106576A0 (en) 1993-12-08
CA2142277A1 (en) 1994-03-03
KR950702837A (ko) 1995-08-23
CN1088095A (zh) 1994-06-22
KR100297610B1 (ko) 2001-10-24
TW380051B (en) 2000-01-21
WO1994004168A1 (en) 1994-03-03
IL106576A (en) 2000-08-13
AU4693793A (en) 1994-03-15
ZA935918B (en) 1994-03-09
EP0655925A1 (de) 1995-06-07
DE69333497T2 (de) 2005-01-13
CA2142277C (en) 2000-01-18
JPH08500108A (ja) 1996-01-09
MX9304925A (es) 1994-08-31
EP0655925B1 (de) 2004-04-28
CZ28395A3 (en) 1995-10-18
JP2008115194A (ja) 2008-05-22
CZ295849B6 (cs) 2005-11-16
AU687356B2 (en) 1998-02-26
ATE265217T1 (de) 2004-05-15

Similar Documents

Publication Publication Date Title
NO169291C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt tetrapyrrol-amino-dicarboxylsyreaddukt
FR2442054A1 (fr) Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant
DE3568272D1 (en) 4-vinylbenzoic-acid derivatives, their preparation and their use as therapeutical compositions and as ligands
MY110734A (en) Improvements in or relating to dioic acids.
DE3588023D1 (de) Mittel zur Behandlung von Herzerkrankungen.
NZ314839A (en) 1,25-Dihydroxy-16,23Z-diene-20-epi-16-ene-cholecalciferol (Vitamin D3) analogues
ATE265217T1 (de) Antikrebs-therapeutische zusammensetzungen die molke-proteinkonzentrat enthalten
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
CA2028629A1 (en) Antiandrogenically-effective pharmaceutical compositions
BE900012A (fr) Nouveau peptide.
ATE174798T1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
MX9702926A (es) L-eritrosilnucleosidos.
CA2100720A1 (en) Medicinal composition comprising tcf-ii
MX9702927A (es) L-piranosilnucleosidos.
DE3374066D1 (en) N-acyl derivatives of peptides, their manufacture and use in combating diseases and means therefor
ATE65027T1 (de) Behandlung von parasiterkrankungen.
FR2592302A1 (fr) Compositions cosmetiques pour le traitement de la peau et des cheveux gras, a base de di(beta-hydroxyethyl) sulfoxyde, et leur application.
IT1268409B1 (it) Prodotto per il trattamento terapeutico di dermatiti da contatto e psoriasi

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: 2458781 CANADA INC., VAUDREUIL, QUEBEC, CA